111 related articles for article (PubMed ID: 37984749)
1. Natural isoflavone glabridin targets PI3Kγ as an adjuvant to increase the sensitivity of MDA-MB-231 to tamoxifen and DU145 to paclitaxel.
Lin H; Ai D; Liu Q; Wang X; Chen Q; Hong Z; Tao Y; Gao J; Wang L
J Steroid Biochem Mol Biol; 2024 Feb; 236():106426. PubMed ID: 37984749
[TBL] [Abstract][Full Text] [Related]
2. The toxicity mechanism of glabridin in prostate cancer cells is involved in reactive oxygen species-dependent PI3K/Akt pathway: Integrated utilization of bioinformatic analysis and in vitro test validation.
Zhang F; Wang F; Li W; Liang L; Sang X
Environ Toxicol; 2022 Dec; 37(12):2937-2946. PubMed ID: 36029289
[TBL] [Abstract][Full Text] [Related]
3. Calycosin inhibits triple-negative breast cancer progression through down-regulation of the novel estrogen receptor-α splice variant ER-α30-mediated PI3K/AKT signaling pathway.
Li Y; Hu S; Chen Y; Zhang X; Gao H; Tian J; Chen J
Phytomedicine; 2023 Sep; 118():154924. PubMed ID: 37393829
[TBL] [Abstract][Full Text] [Related]
4. Andrographolide Exhibits Anticancer Activity against Breast Cancer Cells (MCF-7 and MDA-MB-231 Cells) through Suppressing Cell Proliferation and Inducing Cell Apoptosis via Inactivation of ER-α Receptor and PI3K/AKT/mTOR Signaling.
Tohkayomatee R; Reabroi S; Tungmunnithum D; Parichatikanond W; Pinthong D
Molecules; 2022 May; 27(11):. PubMed ID: 35684480
[TBL] [Abstract][Full Text] [Related]
5. Lupiwighteone induces caspase-dependent and -independent apoptosis on human breast cancer cells via inhibiting PI3K/Akt/mTOR pathway.
Won YS; Seo KI
Food Chem Toxicol; 2020 Jan; 135():110863. PubMed ID: 31604113
[TBL] [Abstract][Full Text] [Related]
6. Daidzin targets epithelial-to-mesenchymal transition process by attenuating manganese superoxide dismutase expression and PI3K/Akt/mTOR activation in tumor cells.
Yang MH; Jung SH; Um JY; Kumar AP; Sethi G; Ahn KS
Life Sci; 2022 Apr; 295():120395. PubMed ID: 35181309
[TBL] [Abstract][Full Text] [Related]
7. The flavonoid glabridin attenuates 2-deoxy-D-ribose-induced oxidative damage and cellular dysfunction in MC3T3-E1 osteoblastic cells.
Kim HS; Suh KS; Ko A; Sul D; Choi D; Lee SK; Jung WW
Int J Mol Med; 2013 Jan; 31(1):243-51. PubMed ID: 23128413
[TBL] [Abstract][Full Text] [Related]
8. Study of the PI3K/Akt/mTOR signaling pathway in vitro and molecular docking analysis of periplocin inhibits cell cycle progression and induces apoptosis in MDA-MB-231.
Liu X; Liu J; Yan B; Quan Z; Wang X; Ma Y; Alarfaj AA; Yan L
Environ Toxicol; 2024 Jan; 39(1):444-456. PubMed ID: 37792628
[TBL] [Abstract][Full Text] [Related]
9. The Combinatory Effects of Glabridin and Tamoxifen on Ishikawa and MCF-7 Cell Lines.
Jen SH; Wei MP; Yin AC
Nat Prod Commun; 2015 Sep; 10(9):1573-6. PubMed ID: 26594762
[TBL] [Abstract][Full Text] [Related]
10. Tamoxifen induces apoptosis through cancerous inhibitor of protein phosphatase 2A-dependent phospho-Akt inactivation in estrogen receptor-negative human breast cancer cells.
Liu CY; Hung MH; Wang DS; Chu PY; Su JC; Teng TH; Huang CT; Chao TT; Wang CY; Shiau CW; Tseng LM; Chen KF
Breast Cancer Res; 2014 Sep; 16(5):431. PubMed ID: 25228280
[TBL] [Abstract][Full Text] [Related]
11. Dietary isoflavone daidzein synergizes centchroman action via induction of apoptosis and inhibition of PI3K/Akt pathway in MCF-7/MDA MB-231 human breast cancer cells.
Kaushik S; Shyam H; Sharma R; Balapure AK
Phytomedicine; 2018 Feb; 40():116-124. PubMed ID: 29496164
[TBL] [Abstract][Full Text] [Related]
12. Evodiamine as the Active Compound of Evodiae fructus to Inhibit Proliferation and Migration of Prostate Cancer through PI3K/AKT/NF-
Lei Y; Chan M; Liu H; Lyu W; Chen L; Zhong Y; Gan H; Wang M; Qi M; Guo Y; Liu J; Zhang E
Dis Markers; 2022; 2022():4399334. PubMed ID: 35899176
[TBL] [Abstract][Full Text] [Related]
13. Induction of apoptosis and autophagy via sirtuin1- and PI3K/Akt/mTOR-mediated pathways by plumbagin in human prostate cancer cells.
Zhou ZW; Li XX; He ZX; Pan ST; Yang Y; Zhang X; Chow K; Yang T; Qiu JX; Zhou Q; Tan J; Wang D; Zhou SF
Drug Des Devel Ther; 2015; 9():1511-54. PubMed ID: 25834399
[TBL] [Abstract][Full Text] [Related]
14. The combined therapy of miR-383-5p restoration and paclitaxel for treating MDA-MB-231 breast cancer.
Dastmalchi N; Azarbarzin S; Safaralizadeh R; Khojasteh SMB; Shadbad MA; Amini M; Baghbanzadeh A; Asl ER; Baghbani E; Lotfinejad P; Baradaran B
Med Oncol; 2021 Nov; 39(1):9. PubMed ID: 34761351
[TBL] [Abstract][Full Text] [Related]
15.
Kapkoti DS; Singh S; Alam S; Khan F; Luqman S; Bhakuni RS
Nat Prod Res; 2020 Jun; 34(12):1735-1742. PubMed ID: 30580626
[TBL] [Abstract][Full Text] [Related]
16. Keratinocyte growth factor (KGF) regulates estrogen receptor-alpha (ER-alpha) expression and cell apoptosis via phosphatidylinositol 3-kinase (PI3K)/Akt pathway in human breast cancer cells.
Chang HL; Sugimoto Y; Liu S; Wang LS; Huang YW; Ye W; Lin YC
Anticancer Res; 2009 Aug; 29(8):3195-205. PubMed ID: 19661335
[TBL] [Abstract][Full Text] [Related]
17. Inhibitory role of large intergenic noncoding RNA-ROR on tamoxifen resistance in the endocrine therapy of breast cancer by regulating the PI3K/Akt/mTOR signaling pathway.
Lu PW; Li L; Wang F; Gu YT
J Cell Physiol; 2019 Feb; 234(2):1904-1912. PubMed ID: 30145819
[TBL] [Abstract][Full Text] [Related]
18. Hypericum roeperianum bark extract suppresses breast cancer proliferation via induction of apoptosis, downregulation of PI3K/Akt/mTOR signaling cascade and reversal of EMT.
Guefack MF; Talukdar D; Mukherjee R; Guha S; Mitra D; Saha D; Das G; Damen F; Kuete V; Murmu N
J Ethnopharmacol; 2024 Jan; 319(Pt 1):117093. PubMed ID: 37634746
[TBL] [Abstract][Full Text] [Related]
19. Inhibitory effects of everolimus in combination with paclitaxel on adriamycin-resistant breast cancer cell line MDA-MB-231.
Xu T; Liu P; Li Q; Shi C; Wang X
Taiwan J Obstet Gynecol; 2020 Nov; 59(6):828-834. PubMed ID: 33218396
[TBL] [Abstract][Full Text] [Related]
20. [Regulatory effects of glabridin and quercetin on energy metabolism of breast cancer cells].
Li LJ; Li GW; Xie Y
Zhongguo Zhong Yao Za Zhi; 2019 Sep; 44(17):3786-3791. PubMed ID: 31602954
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
